Medical Properties Trust, Inc.

As of October 31, 2025, Medical Properties Trust, Inc. shows a bullish technical trend despite mixed signals from some indicators, having underperformed the S&P 500 recently but outperformed it year-to-date.

As of October 31, 2025, Medical Properties Trust, Inc. shows a bullish technical trend supported by positive MACD and Bollinger Bands, despite some mixed signals from Dow Theory and OBV, with a year-to-date return of 30.89% outperforming the S&P 500.

As of October 31, 2025, Medical Properties Trust, Inc. shows a bullish technical trend, supported by positive MACD and Bollinger Bands, despite some caution from mildly bearish signals in Dow Theory and OBV.

As of October 24, 2025, Medical Properties Trust, Inc. shows a bullish technical trend with a year-to-date return of 29.87%, outperforming the S&P 500, despite some mixed long-term performance signals.

As of October 24, 2025, Medical Properties Trust, Inc. shows a bullish technical trend with strong weekly indicators and a year-to-date return of 29.87%, despite mixed signals from Dow Theory and underperformance over the past three years.

As of October 24, 2025, Medical Properties Trust, Inc. shows a bullish technical trend, with strong short-term indicators despite mixed longer-term performance, having returned 29.87% year-to-date compared to the S&P 500's 15.47%.

As of October 3, 2025, Medical Properties Trust, Inc. shows a mildly bullish trend with positive momentum indicators like the MACD and Bollinger Bands, despite some short-term weakness in moving averages, while it has outperformed the S&P 500 recently but underperformed over longer periods.

As of October 3, 2025, Medical Properties Trust, Inc. shows a mildly bullish trend supported by positive MACD and Bollinger Bands, despite some bearish signals in daily moving averages and a year-to-date underperformance compared to the S&P 500.

As of October 3, 2025, Medical Properties Trust, Inc. shows a mildly bullish trend supported by positive MACD and Bollinger Bands, but caution is advised due to mixed signals and poor long-term performance compared to the S&P 500.

As of September 12, 2025, Medical Properties Trust, Inc. shows a neutral technical trend with mixed signals, being mildly bullish on MACD and Bollinger Bands but mildly bearish on moving averages, while outperforming the S&P 500 recently but underperforming over the past year.

As of October 26, 2023, Medical Properties Trust, Inc. is considered risky and overvalued due to a low Price to Book Value of 0.57, a high EV to EBITDA ratio of 3.71, a negative ROE of -8.48%, and mixed stock performance, despite a recent 1-week return of 9.33% and year-to-date return of 27.59%.

As of June 20, 2025, the trend has shifted to mildly bullish due to daily moving averages, but caution is advised as weekly indicators remain bearish and monthly signals are mixed.

As of March 2022, the management team of Medical Properties Trust, Inc. includes Edward Aldag (Chairman, President, CEO), R. Steven Hamner (CFO, Executive VP, Director), and Michael Stewart (Lead Independent Director), along with Independent Directors G. Steven Dawson, Caterina Mozingo, Elizabeth Pitman, and Daniel Sparks. They oversee the company's strategic direction and operations.

Medical Properties Trust, Inc. is a real estate investment trust (REIT) that invests in net-leased healthcare facilities. As of March 2025, it has a market cap of approximately $2.67 billion, a dividend yield of 7.19%, and reported a net profit loss of $118 million.

As of Jun 18, Medical Properties Trust, Inc. has a market capitalization of 2,667.55 million, categorizing it as a Small Cap company, with recent net sales of 948.03 million and a net profit of -1,651.98 million.